Clinical Trial Update: Effect of Rifabutin on the Pharmacokinetics of Oral Cabotegravir in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating how rifabutin affects the pharmacokinetics of oral cabotegravir in healthy subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection
• Infection

Drugs mentioned

• RIFABUTIN (Rifabutin)
• cabotegravir (cabotegravir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus, HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2019-02-04